The Stromal Vascular Fraction Market To Go Along The "Consumerization Of Healthcare" Way

Stromal vascular fraction is gaining significant importance in various fields, including internal medicine, orthopaedics, plastic and general surgery, and wound healing. Ease of harvest, abundant availability, and stable phenotype are some factors increasing the demand for stromal vascular fraction.

Want Insights To Stromal Vascular Fraction Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/20914

Also, stromal vascular fraction secretes several soluble factors with anti-inflammatory, immunomodulatory, and analgesic effects, which leads to an alternative treatment option for various diseases, significantly benefitting the growth of the stromal vascular fraction market during the forecast period. Delivery of stromal vascular fraction by intra-articular injection has advantages over surgical implantation, such as less invasiveness, better patient compliance, and lower cost.

The global stromal vascular fraction market was valued at US$ 76 Mn in 2018, and is expected to witness a CAGR of around 4% over the forecast period (2019-2029).

Company Profiles:

Cytori Therapeutics Inc.
IntelliCell BioSciences Inc.
Cellular Biomedicines Group, Inc
GE Healthcare (Biosafe Group SA)
Lifecell Corporation (Allergen PLC)
Tissue Genesis Inc
InGeneron, Inc.
Human made AG
MEDICAN CO., LTD

Planning To Conclude Your Strategy On A Decisive Note In The Stromal Vascular Fraction Market? Glance Through The "Methodology" Implied! https://www.persistencemarketresearch.com/methodology/20914

Key Takeaways of Stromal Vascular Fraction Market Study

SVF isolation products have emerged as the largest segment by product, representing 80% of revenue share in the stromal vascular fraction market.

The soft tissue segment, under application, contributes a significant market share in the stromal vascular fraction market, owing to the capability to secrete paracrine factors that help in initiating tissue repair and accelerate wound closure.

Rising awareness about stem cell therapy for various treatments, increasing volume of cosmetic surgeries performed, and surging demand for aesthetic and reconstructive therapies have contributed to the dominance of North America in the global stromal vascular fraction market.

The hospitals segment, under end user, is projected to account for half of the share of the stromal vascular fraction market during the forecast period, as hospitals are highly preferred for the entire process, starting from lipoaspiration, SVF isolation & processing, and finally injecting them at the desired site.

"Stromal vascular fraction has emerged as an efficient alternative in the field of regenerative medication. However, better-structured and significant clinical investigations need to be carried out to demonstrate and define the therapeutic potential of stromal vascular fraction," says a PMR analyst.

How About Knowing The Product/Technology Driving The Stromal Vascular Fraction Market Before Investing Therein? Click The "Purchase Now" Button Of Our Stromal Vascular Fraction Market Report! https://www.persistencemarketresearch.com/checkout/20914

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.